Josiel Mileno Mack

Josiel Mileno Mack

Auto-generated profile, based on publicly available information

Josiel Mileno Mack

Laboratory of Experimental Neuroscience (LaNEx), Postgraduate Program in Health Sciences, Universidade do Sul de Santa Catarina, Pedra Branca, Palhoça, SC, Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JMJosiel Mileno Mack
Josiel Mileno Mack
MSMarissa Giovanna Schamne
Marissa Giovanna Schamne
TSTuane Bazanella Sampaio
Tuane Bazanella Sampaio
RPRenata Aparecida Nedel Pértile
Renata Aparecida Nedel Pértile
PFPedro A Fernandes
Pedro A Fernandes
RPRui Daniel Prediger
Rui Daniel Prediger
Melatonin is synthesized by several tissues besides the pineal gland, and beyond its regulatory effects in light‐dark cycle, melatonin is a hormone with neuroprotective, anti‐inflammatory, and antioxidant properties. Melatonin acts as a free‐radical scavenger, reducing reactive species and improving mitochondrial homeostasis. Melatonin also regulates the expression of neurotrophins that are involved in the survival of dopaminergic neurons and reduces α‐synuclein aggregation, thus protecting the dopaminergic system against damage. The unbalance of pineal melatonin synthesis can predispose the organism to inflammatory and neurodegenerative diseases such as Parkinson’s disease (PD). The aim of this review is to summarize the knowledge about the potential role of the melatoninergic system in the pathogenesis and treatment of PD. The literature reviewed here indicates that PD is associated with impaired brain expression of melatonin and its receptors MT1 and MT2. Exogenous melatonin treatment presented an outstanding neuroprotective effect in animal models of PD induced by different toxins, such as 6‐hydroxydopamine (6‐OHDA), 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP), rotenone, paraquat, and maneb. Despite the neuroprotective effects and the improvement of motor impairments, melatonin also presents the potential to improve nonmotor symptoms commonly experienced by PD patients such as sleep and anxiety disorders, depression, and memory dysfunction.

1 January 2026 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
ELElisa Mitkus Flores Lins
Elisa Mitkus Flores Lins
ACAnelise Leal Vieira Cubas
Anelise Leal Vieira Cubas
BOBruna Hoffmann de Oliveira
Bruna Hoffmann de Oliveira
EMEduarda Behenck Medeiros
Eduarda Behenck Medeiros
KMKhiany Mathias
Khiany Mathias
FBFranciane Bobinski
Franciane Bobinski
Spent ground coffee oil (SGCO), rich in antioxidants and bioactive compounds, exhibits anti-inflammatory and analgesic properties and therefore warrants investigation in inflammatory pain models. This study aimed to investigate the topical effects of SGCO on hyperalgesia, emotional behavior, and inflammation-related mechanisms in a Complete Freund’s Adjuvant (CFA)-induced inflammation model. SGCO was extracted from spent coffee grounds via non-thermal plasma (NTP) and incorporated into a transdermal vehicle at 10%, 20%, and 30% (w/w). Female Balb/c mice (2 months old, n = 8/group) received daily topical applications of SGCO for 14 days after CFA-induced inflammation. Mechanical and cold nociception and paw edema were assessed. The concentration with the strongest antihyperalgesic effect (20%) was used in further experiments assessing mechanical conflict avoidance, anxiety- and depression-like behaviors, cytokine and oxidative parameters (paw, spinal cord, hippocampus, and prefrontal cortex), and inflammatory pathways in paw tissue. SGCO at 10%, 20%, and 30% produced significant antihyperalgesic effects without affecting paw edema, with 20% providing a sustained effect for 11 days. SGCO 20% was associated with reduced anxiety-like behavior, improved hedonic-like behavior without altering locomotion, and reduced pro-inflammatory cytokines (interleukin-1β and tumor necrosis factor), myeloperoxidase activity, phospho-Akt1/2/3, and NLRP3 in paw tissue. Additionally, it decreased protein carbonyl levels while increasing sulfhydryl group levels in the prefrontal cortex and hippocampus. These findings indicate that SGCO modulates inflammatory and oxidative pathways associated with CFA-induced inflammation and produces measurable effects on nociceptive and behavioral outcomes. Although the magnitude of the effects was generally modest, SGCO obtained via NTP technology may represent a low-cost and environmentally sustainable source of bioactive compounds for further preclinical investigation. Graphical Abstract

20 August 2026 in Journal of Autism and Developmental Disorders
Verified
Journal Article
Closed access
PDF file
MMMarilia Barbosa de Matos
Marilia Barbosa de Matos
PLPaulo B. N. Liberalesso
Paulo B. N. Liberalesso
TBTiago Rehlander Bara
Tiago Rehlander Bara
GFGiusi Figliano
Giusi Figliano
JMJosiel Mileno Mack
Josiel Mileno Mack